Satoshi Ito is currently the Japan Asset Strategy Leader for Neuroscience at AbbVie, a role they have held since 2025. Previously, they worked at Eisai Co., Ltd. in various leadership positions focusing on clinical trials and drug development for Alzheimer's disease and other neurodegenerative disorders. Satoshi earned a Master of Science in Neuroscience from Tohoku University in 2007. Their extensive experience includes driving diagnostic strategy and clinical implementation for therapeutics on a global scale.
This person is not in the org chart
This person is not in any teams
This person is not in any offices